Healthcare
SR One set to deploy $500m fund following GSK spin-out
CEO Simeon George tells Unquote that the firm is seeing early-stage and later-stage opportunities
Waterland's Athera makes three bolt-ons
Germany-based physiotherapy group has made 11 add-ons since Waterland's investment in 2019
VCs in $125m round for Atai Life Sciences
Mental health treatment compound developer is backed by investors including
Ardian buys Inovie minority
Ardian has acquired a minority stake in medical diagnostics company Inovie.
BPI France, Omnes lead €12m series-A for AlgoTherapeutix
Company intends to use the proceeds to finance the clinical development of its lead candidate ATX01
Mercia-backed Abingdon Health files for IPO
Abingdon Health was in discussions with potential investors for an IPO to raise around £100m
GSK spinout SR One closes $500m debut fund
Biotechnology-focused vehicle will invest in Europe and the US, with GSK as cornerstone investor
Viking, General Atlantic lead $80m round for Pharvaris
Foresite, Bain Life Sciences, VenBio Partners and Venroc also back the biotechnology company
Sale of EQT-owned Fertin Pharma to launch in Q1 2021
GP is aiming to close the deal before the second half of 2021
Bridgepoint-backed Diaverum to launch IPO
Planned IPO could reportedly value at the renal care clinics group at more than €2bn
Auctus buys majority stake in nursing home chain Mirabelle
GP founds Mirabelle Holding alongside Mirabelle Care, Thomas Zethin and Sander van Adelberg
Kurma, Sunstone lead CHF 20m round for Synendos Therapeutics
Investors including HTGF also backed the central nervous system disorder therapy developer
Turenne backs ABL Lyon
GP invests via Turenne Capital Santé 2, a healthcare-dedicated fund with a €165m hard-cap
Capiton's Euro Vital Pharma buys Principle Healthcare
Capiton acquired the health products manufacturer in 2018; the company continues to seek bolt-ons
Vesalius Biocapital leads €50m round for CatalYm
VCs including Forbion, BioGeneration Ventures and Coparion also back the immunotherapy developer
MCH sells Lenitudes, invests in Atrys
Sale ends a six-year holding period for MCH, which acquired a 66.5% stake in Lenitudes via its third fund
Novalpina buys majority stake in Laboratoire XO
Deal reportedly values the company at more than €300m, and unitranche debt was provided by debt fund manager Ares
Bridgepoint buys minority stake in Diagnostiskt Centrum Hud
GP will help the company's expansion further into the Nordic region
Agilitas sells Exemplar to Ares Management
Sale ends a four-year holding period for Agilitas, which backed the company via its Agilitas 2015 Private Equity Fund
Epidarex sells Sirakoss to VC-backed OssDsign
Epidarex Capital initially backed the £3.1m series-A for the bone graft substitutes developer in 2014
LBO France completes FH Ortho trade sale
LBO France acquired the company via its €154m Hexagone III fund in 2014
Bridgepoint-backed Diaverum plans IPO in November – reports
Transaction could reportedly value the company at more than €2bn
TVM Capital closes LSI II on $478m
Vehicle is TVM's largest ever fund and the second in its exclusively life-sciences-focused strategy
Digital doctors here to stay as telemedicine deals surge
Rise in demand for telemedicine – and promising returns for investors that have been targeting the space – looks set to continue